Palsonify (Paltusotine)

Paltusotine is a medicine for acromegaly, a condition where the body makes too much growth hormone. It is a pill taken by mouth once a day. It works like a natural hormone that tells the pituitary gland to make less growth hormone.

Brand names:Palsonify
Medication

What people taking Palsonify (Paltusotine) report

Every report comes from a Lived member, sent anonymously.

Have you tried Palsonify (Paltusotine) for Acromegaly?

NameHow it went

About Palsonify (Paltusotine)

What It's For

Paltusotine, sold as Palsonify, is a once-daily tablet for adults with acromegaly. Acromegaly is a rare hormone disorder in which the pituitary gland, a small gland at the base of the brain, releases too much growth hormone over a long period. In more than 9 out of 10 people the cause is a noncancerous pituitary tumor called an adenoma. The excess hormone gradually enlarges the hands, feet and facial features, and it raises the risk of type 2 diabetes, high blood pressure and heart disease. Surgery to remove the tumor is usually the first treatment. Paltusotine is approved for adults whose acromegaly was not controlled by surgery, or who cannot have surgery. It belongs to the same broad family as octreotide and lanreotide, medicines that are most often given as injections, and offers a daily pill as an alternative. It is approved for adults; its safety and effectiveness in children have not been established.

How It Works

Somatostatin is a natural hormone that, among other things, tells the pituitary gland to release less growth hormone. Paltusotine copies this signal. It attaches to one specific type of somatostatin receptor (type 2) on the pituitary cells, and that switches down growth hormone release. Growth hormone itself is not what drives most of the changes in acromegaly. It signals the liver to make a second hormone, insulin-like growth factor 1 (IGF-1), which causes tissue growth and affects how the body handles sugar and fat. When paltusotine lowers growth hormone, IGF-1 falls too. That is why IGF-1 is the main blood test used to judge whether treatment is working. Paltusotine controls hormone levels rather than removing the tumor, so it is a treatment, not a cure.

Dosage & Administration

Palsonify comes as 20 mg and 30 mg tablets, so a 40 mg or 60 mg dose is made up of more than one tablet. The usual starting dose is 40 mg once a day. If stomach side effects are hard to tolerate at first, the prescriber may lower it to 20 mg for a short time and then return to 40 mg. After 2 to 4 weeks, an IGF-1 blood test guides whether to increase to 60 mg once a day, which is the usual top dose. Timing around meals is part of the approved instructions. Take the tablet with water on an empty stomach, at least 6 hours after eating and at least 1 hour before the next meal. For many people the simplest way to do this is first thing in the morning after an overnight fast, then waiting an hour before breakfast. Keeping this routine consistent helps the medicine work as expected.

Side Effects

Digestive side effects are the most common. In the main trials, diarrhea affected roughly a quarter to a third of people taking paltusotine, compared with 11 to 14% on placebo, and abdominal pain, nausea and reduced appetite were also more frequent. These effects mostly appeared in the first two months and typically lasted about one to two and a half weeks. A slower heart rate, a sense of a pounding or racing heartbeat (palpitations) and higher blood sugar were also reported. Like other medicines in its family, paltusotine can slow the gallbladder and lead to gallstones. About 6 in 100 trial participants developed gallstones or a related problem, mostly within the first nine months, and a few had complications such as an inflamed gallbladder or pancreatitis (inflammation of the pancreas). Contact the care team about pain in the upper abdomen, back or just under the right arm, especially with nausea or vomiting, and about an irregular heartbeat. Some people develop greasy, pale or oily stools, bloating and unexplained weight loss. This can mean the body is not absorbing fat well, sometimes because the pancreas is making fewer digestive enzymes. New or worsening symptoms like these are worth reporting so the cause can be checked.

Interactions & Warnings

Proton pump inhibitors (PPIs), a widely used type of stomach-acid reducer for heartburn and reflux, lower the amount of paltusotine the body absorbs. Someone already taking a PPI may need a higher paltusotine dose, and people on 60 mg are advised to avoid PPIs. Some medicines and supplements also make the liver break paltusotine down faster, which can reduce its effect and call for a dose increase. Examples include the seizure medicines carbamazepine and phenytoin, the tuberculosis antibiotic rifampin, the HIV medicine efavirenz and the herbal supplement St. John's wort. Paltusotine in turn lowers levels of cyclosporine, an immune-suppressing drug used after organ transplants and for some autoimmune conditions, so cyclosporine levels need closer monitoring. A pharmacist can check a full medication and supplement list for these interactions. Paltusotine can shift blood sugar up or down. People with diabetes should expect more frequent glucose checks when starting or changing the dose, and their diabetes medicines may need adjusting. Because it can slow the heart rate or affect the heart's electrical rhythm, doses of other heart-slowing medicines, such as beta-blockers, may need to change. It can also reduce thyroid hormone production over time. There is not enough information to know whether paltusotine is safe during pregnancy, and it is not known whether it passes into breast milk, although it does in animals. Anyone pregnant, planning pregnancy or breastfeeding should talk through the options with their endocrinologist.

What to Expect

The first IGF-1 check usually comes a few weeks after starting, and the dose is adjusted from there. In a 24-week trial of adults whose acromegaly was not controlled, 56% of those taking paltusotine brought IGF-1 down to the top of the normal range or below, compared with 5% on placebo. In a 36-week trial of people switching from monthly octreotide or lanreotide injections, 83% kept their IGF-1 in the normal range, compared with 4% of those switched to placebo. Not everyone reaches control on paltusotine alone, and a different or added treatment may be needed. Symptoms such as headaches, joint pain, sweating and fatigue tend to track with hormone control, though how much they change varies from person to person. A small long-term study found that hormone levels, symptoms and tumor size stayed stable for up to four years on paltusotine. Because medicines for acromegaly control the disease rather than cure it, ongoing follow-up is part of treatment. Expect regular IGF-1 tests, blood sugar checks, periodic thyroid tests, attention to gallbladder symptoms and, when needed, vitamin B12 levels, because medicines in this family can lower B12.

Questions to Ask Your Doctor

  1. 1.Why is paltusotine a better fit for me than injections or another medicine?
  2. 2.What IGF-1 result are we aiming for, and when will we decide whether 40 mg or 60 mg is right?
  3. 3.Do any of my current medicines, especially acid reducers, heart medicines or diabetes treatment, need to change?
  4. 4.How will we watch for gallstones, thyroid changes and blood sugar problems over time?
  5. 5.If paltusotine does not fully control my acromegaly, what would we add or switch to?

Last reviewed • Oct 2026

Educational content, not medical advice.